Case Study: Top-10 Global Pharmaceutical Company achieves record two-week database lock and accelerated Phase III closeout with Medable

Setting a new client standard in study closeout timelines

Top-10 Global Pharmaceutical Company partnered with Medable for a pivotal Phase III diabetes study to address inefficiencies in traditional study delivery and closeout processes and accelerate time to market. The sponsor used Medable’s eCOA+, the Medable platform, and provisioned devices to support a more efficient, digitally enabled trial in a very competitive therapeutic area.

Medable analyzed startup procedures, implemented reusable process and technology standards, provided proactive data-query resolution, comprehensive CRA/site support and customized training, and ensured global-local alignment. As a result, Medable helped the client achieve database lock and a press release in just two weeks, 95% participant data compliance, 85% study completion, markedly faster recruitment, and a redefined Phase III closeout process that accelerated the path to commercialization.